Australian healthcare brand outperforms weight loss drug records in clinical trials
Disclaimer: This article is not intended to be medical advice. For professional guidance, please consult a GP.
Obesity* in Australia is a significant public health concern* that has been steadily increasing over the past few years. It's a multifaceted issue influenced by various factors such as diet*, lifestyle*, genetics, and socio-economic status.
According to data from the Australian Institute of Health and Welfare, as of 2017-2018, around two-thirds* (67 per cent) of Australian adults were classified as overweight or obese*, with rates being higher among men (74 per cent) than women (61 per cent).
As the country grapples with this crisis, the race is on to find new, effective weight loss solutions*.
Much of the attention has focused on promising new medications* like Glucagon-like peptide-1 (GLP-1) receptor agonists (for example, Ozempic), which improve blood sugar control*.
However, an Aussie startup* is leaving billion-dollar pharmaceutical giants in the dust.
By combining medications with personalised coaching* and support*, Juniper* consistently achieves great weight loss* results.
A recent study published in the Journal of Diabetes, Obesity and Metabolism has found that Juniper's Weight Reset Program* is substantially more effective than GLP-1 medications* alone in helping patients lose significant amounts of weight.
The study revealed that Juniper's program* was 450 per cent more effective* than medications in achieving weight loss goals*.
Nearly 90 per cent* of those on Juniper's regimen lost at least 5 per cent* of their body weight within 32 weeks*, with one in four patients* losing an impressive 15 per cent or more.
In contrast, only around 20 per cent saw that level of weight loss* from the medication by itself.
While GLP-1 drugs are a significant step forward in battling obesity*, Juniper recognised a much better approach* to battle this epidemic.
That's why they pair the power of GLP-1s with one-on-one health coaching*, customised nutrition and fitness plans*, and 24/7 access to medical experts*.
Juniper's Clinical Director, Dr Matt Vickers, claimed that this emphasis on a sustainable lifestyle* change sets their program apart.
‘This study reveals that even though GLP-1 medications are often described as a “silver bullet” for weight management*, patients may achieve greater outcomes when they also receive personalised diet*, exercise* and medical guidance* from practitioners to help them change lifestyle habits* for the long-term,’ he explained.
Many think that effective weight loss treatments are an approach available only to the rich and famous who can afford a team of in-person doctors*, dietitians*, and personal trainers*.
But Juniper* is making effective obesity treatment* more accessible for everyday Aussies.
But how does the Weight Reset Program* work?
The only comprehensive digital obesity management program* in Australia starts with an online quiz* and consultation* with an accredited Australian practitioner*.
Following this, patients receive a personalised plan* delivered to their door, complete with easy-to-follow instructions* for beginning treatment at home.
Throughout the patient’s journey, Juniper* provides ongoing support* and follow-up care*, helping patients establish habits for long-term success*.
More than that, patients also have access to:
Juniper’s patients* shared their experience with the Weight Reset Program* and how it helped them achieve their ideal weight*.
‘As a mum, I’m always prioritising everybody else. This is about doing something for me,’ Trish, who has been a patient* since January 2023, said.
Meanwhile, Rosemary, who had been a patient since August 2022, stated: ‘I feel more motivated* and so much happier* within myself.’
With obesity* costing the Australian economy over $8 billion per year and driving skyrocketing rates of chronic diseases like diabetes and heart disease, the potential impact of Juniper's innovation* can't be stressed enough.
While pharmaceutical giants may have deeper pockets, this Aussie healthcare brand* is proving that when it comes to obesity*, a smart, localised, patient-centric approach* can more than level the playing field.
As the obesity epidemic* rages on, Juniper* offers a welcome ray of hope that we may finally have a scalable solution to help millions of Aussies reclaim their health—and their lives.
*Please note, members, that this is a sponsored article. All content that has an asterisk next to it means we may get a commission when you click on a link—at no cost to you! We do this to assist with the costs of running the SDC. Thank you!
Obesity* in Australia is a significant public health concern* that has been steadily increasing over the past few years. It's a multifaceted issue influenced by various factors such as diet*, lifestyle*, genetics, and socio-economic status.
According to data from the Australian Institute of Health and Welfare, as of 2017-2018, around two-thirds* (67 per cent) of Australian adults were classified as overweight or obese*, with rates being higher among men (74 per cent) than women (61 per cent).
As the country grapples with this crisis, the race is on to find new, effective weight loss solutions*.
Much of the attention has focused on promising new medications* like Glucagon-like peptide-1 (GLP-1) receptor agonists (for example, Ozempic), which improve blood sugar control*.
However, an Aussie startup* is leaving billion-dollar pharmaceutical giants in the dust.
By combining medications with personalised coaching* and support*, Juniper* consistently achieves great weight loss* results.
A recent study published in the Journal of Diabetes, Obesity and Metabolism has found that Juniper's Weight Reset Program* is substantially more effective than GLP-1 medications* alone in helping patients lose significant amounts of weight.
The study revealed that Juniper's program* was 450 per cent more effective* than medications in achieving weight loss goals*.
Nearly 90 per cent* of those on Juniper's regimen lost at least 5 per cent* of their body weight within 32 weeks*, with one in four patients* losing an impressive 15 per cent or more.
In contrast, only around 20 per cent saw that level of weight loss* from the medication by itself.
While GLP-1 drugs are a significant step forward in battling obesity*, Juniper recognised a much better approach* to battle this epidemic.
That's why they pair the power of GLP-1s with one-on-one health coaching*, customised nutrition and fitness plans*, and 24/7 access to medical experts*.
Juniper's Clinical Director, Dr Matt Vickers, claimed that this emphasis on a sustainable lifestyle* change sets their program apart.
‘This study reveals that even though GLP-1 medications are often described as a “silver bullet” for weight management*, patients may achieve greater outcomes when they also receive personalised diet*, exercise* and medical guidance* from practitioners to help them change lifestyle habits* for the long-term,’ he explained.
Many think that effective weight loss treatments are an approach available only to the rich and famous who can afford a team of in-person doctors*, dietitians*, and personal trainers*.
But Juniper* is making effective obesity treatment* more accessible for everyday Aussies.
But how does the Weight Reset Program* work?
The only comprehensive digital obesity management program* in Australia starts with an online quiz* and consultation* with an accredited Australian practitioner*.
Following this, patients receive a personalised plan* delivered to their door, complete with easy-to-follow instructions* for beginning treatment at home.
Throughout the patient’s journey, Juniper* provides ongoing support* and follow-up care*, helping patients establish habits for long-term success*.
More than that, patients also have access to:
- Medically backed treatments*
- An online clinic* without waiting times
- Unlimited follow-ups* with their Medical Support Team*
- Free shipping* and free cancellation* anytime
Juniper’s patients* shared their experience with the Weight Reset Program* and how it helped them achieve their ideal weight*.
‘As a mum, I’m always prioritising everybody else. This is about doing something for me,’ Trish, who has been a patient* since January 2023, said.
Meanwhile, Rosemary, who had been a patient since August 2022, stated: ‘I feel more motivated* and so much happier* within myself.’
With obesity* costing the Australian economy over $8 billion per year and driving skyrocketing rates of chronic diseases like diabetes and heart disease, the potential impact of Juniper's innovation* can't be stressed enough.
While pharmaceutical giants may have deeper pockets, this Aussie healthcare brand* is proving that when it comes to obesity*, a smart, localised, patient-centric approach* can more than level the playing field.
As the obesity epidemic* rages on, Juniper* offers a welcome ray of hope that we may finally have a scalable solution to help millions of Aussies reclaim their health—and their lives.
*Please note, members, that this is a sponsored article. All content that has an asterisk next to it means we may get a commission when you click on a link—at no cost to you! We do this to assist with the costs of running the SDC. Thank you!